- Home
- ABVC vs PMCB Comparison
ABVC vs PMCB Comparison
Compare ABVC & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- PMCB
- Stock Information
- Founded
- ABVC 2015
- PMCB 1996
- Country
- ABVC United States
- PMCB United States
- Employees
- ABVC N/A
- PMCB N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABVC Health Care
- PMCB Health Care
- Exchange
- ABVC Nasdaq
- PMCB Nasdaq
- Market Cap
- ABVC 12.8M
- PMCB 10.5M
- IPO Year
- ABVC N/A
- PMCB N/A
- Fundamental
- Price
- ABVC $0.54
- PMCB $1.69
- Analyst Decision
- ABVC
- PMCB
- Analyst Count
- ABVC 0
- PMCB 0
- Target Price
- ABVC N/A
- PMCB N/A
- AVG Volume (30 Days)
- ABVC 150.8K
- PMCB 15.8K
- Earning Date
- ABVC 03-12-2025
- PMCB 03-17-2025
- Dividend Yield
- ABVC N/A
- PMCB N/A
- EPS Growth
- ABVC N/A
- PMCB N/A
- EPS
- ABVC N/A
- PMCB 0.74
- Revenue
- ABVC $509,788.00
- PMCB N/A
- Revenue This Year
- ABVC N/A
- PMCB N/A
- Revenue Next Year
- ABVC N/A
- PMCB N/A
- P/E Ratio
- ABVC N/A
- PMCB $2.27
- Revenue Growth
- ABVC N/A
- PMCB N/A
- 52 Week Low
- ABVC $0.41
- PMCB $1.39
- 52 Week High
- ABVC $1.73
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- ABVC 47.67
- PMCB 56.22
- Support Level
- ABVC $0.50
- PMCB $1.50
- Resistance Level
- ABVC $0.58
- PMCB $1.80
- Average True Range (ATR)
- ABVC 0.06
- PMCB 0.11
- MACD
- ABVC -0.01
- PMCB 0.01
- Stochastic Oscillator
- ABVC 20.63
- PMCB 61.69
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.